Mauna Kea Technologies SAS (ALMKT) - Net Assets
Based on the latest financial reports, Mauna Kea Technologies SAS (ALMKT) has net assets worth €-29.42 Million EUR (≈ $-34.40 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€12.66 Million ≈ $14.80 Million USD) and total liabilities (€42.08 Million ≈ $49.20 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Mauna Kea Technologies SAS (ALMKT) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-29.42 Million |
| % of Total Assets | -232.39% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -273.08% |
| Growth Volatility | 1369.25 |
Mauna Kea Technologies SAS - Net Assets Trend (2008–2024)
This chart illustrates how Mauna Kea Technologies SAS's net assets have evolved over time, based on quarterly financial data. Also explore Mauna Kea Technologies SAS (ALMKT) total assets for the complete picture of this company's asset base.
Annual Net Assets for Mauna Kea Technologies SAS (2008–2024)
The table below shows the annual net assets of Mauna Kea Technologies SAS from 2008 to 2024. For live valuation and market cap data, see ALMKT market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €-24.39 Million ≈ $-28.51 Million |
-41.17% |
| 2023-12-31 | €-17.28 Million ≈ $-20.20 Million |
+13.29% |
| 2022-12-31 | €-19.93 Million ≈ $-23.29 Million |
-92.83% |
| 2021-12-31 | €-10.33 Million ≈ $-12.08 Million |
+14.44% |
| 2020-12-31 | €-12.08 Million ≈ $-14.12 Million |
-4873.52% |
| 2019-12-31 | €253.00K ≈ $295.78K |
-96.83% |
| 2018-12-31 | €7.98 Million ≈ $9.33 Million |
-52.35% |
| 2017-12-31 | €16.74 Million ≈ $19.58 Million |
+50.08% |
| 2016-12-31 | €11.16 Million ≈ $13.04 Million |
-20.82% |
| 2015-12-31 | €14.09 Million ≈ $16.47 Million |
-22.36% |
| 2014-12-31 | €18.15 Million ≈ $21.22 Million |
-39.82% |
| 2013-12-31 | €30.16 Million ≈ $35.26 Million |
-24.91% |
| 2012-12-31 | €40.16 Million ≈ $46.95 Million |
-22.13% |
| 2011-12-31 | €51.57 Million ≈ $60.30 Million |
+651.57% |
| 2010-12-31 | €6.86 Million ≈ $8.02 Million |
-34.11% |
| 2009-12-31 | €10.41 Million ≈ $12.18 Million |
-28.68% |
| 2008-12-31 | €14.60 Million ≈ $17.07 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Mauna Kea Technologies SAS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1040400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €2.71 Million | % |
| Other Comprehensive Income | €-26.16 Million | % |
| Other Components | €9.46 Million | % |
| Total Equity | €-24.39 Million | 100.00% |
Mauna Kea Technologies SAS Competitors by Market Cap
The table below lists competitors of Mauna Kea Technologies SAS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kincora Copper Ltd
AU:KCC
|
$28.44 Million |
|
ContextVision AB
OL:CONTX
|
$28.45 Million |
|
Chien Wei Precise Technology Co Ltd
TWO:8092
|
$28.46 Million |
|
EMB Mission Bound AB (publ)
ST:NAVIGO-STAM
|
$28.48 Million |
|
C-Com Satellite Systems Inc.
V:CMI
|
$28.43 Million |
|
Okong Corporation
KQ:045060
|
$28.42 Million |
|
TOUAX
PA:ALTOU
|
$28.40 Million |
|
Desoto Resources Ltd
AU:DES
|
$28.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mauna Kea Technologies SAS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -17,277,000 to -24,389,000, a change of -7,112,000.
- Net loss of 10,404,000 reduced equity.
- Share repurchases of 2,088,000 reduced equity.
- New share issuances of 2,088,000 increased equity.
- Other comprehensive income decreased equity by 2,545,000.
- Other factors increased equity by 5,837,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-10.40 Million | -42.66% |
| Share Repurchases | €2.09 Million | -8.56% |
| Share Issuances | €2.09 Million | +8.56% |
| Other Comprehensive Income | €-2.54 Million | -10.44% |
| Other Changes | €5.84 Million | +23.93% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares Mauna Kea Technologies SAS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | €0.16 | €0.18 | x |
| 2011-12-31 | €4.38 | €0.18 | x |
| 2012-12-31 | €2.99 | €0.18 | x |
| 2013-12-31 | €2.20 | €0.18 | x |
| 2014-12-31 | €1.31 | €0.18 | x |
| 2015-12-31 | €0.84 | €0.18 | x |
| 2016-12-31 | €0.54 | €0.18 | x |
| 2017-12-31 | €0.69 | €0.18 | x |
| 2018-12-31 | €0.29 | €0.18 | x |
| 2019-12-31 | €0.01 | €0.18 | x |
| 2020-12-31 | €-0.34 | €0.18 | x |
| 2021-12-31 | €-0.23 | €0.18 | x |
| 2022-12-31 | €-0.38 | €0.18 | x |
| 2023-12-31 | €-0.35 | €0.18 | x |
| 2024-12-31 | €-0.35 | €0.18 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mauna Kea Technologies SAS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -135.91%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-444.01%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | -56.73% | -96.12% | 0.34x | 1.74x | €-4.58 Million |
| 2011 | -15.38% | -158.19% | 0.08x | 1.17x | €-13.09 Million |
| 2012 | -32.51% | -148.20% | 0.18x | 1.22x | €-17.07 Million |
| 2013 | -38.18% | -115.43% | 0.25x | 1.31x | €-14.53 Million |
| 2014 | -77.09% | -127.01% | 0.40x | 1.52x | €-15.81 Million |
| 2015 | -89.72% | -147.92% | 0.38x | 1.60x | €-14.05 Million |
| 2016 | -87.34% | -110.89% | 0.44x | 1.79x | €-10.86 Million |
| 2017 | -61.19% | -153.21% | 0.24x | 1.66x | €-11.92 Million |
| 2018 | -165.67% | -195.52% | 0.34x | 2.48x | €-14.01 Million |
| 2019 | -6036.36% | -179.48% | 0.36x | 93.36x | €-15.30 Million |
| 2020 | 0.00% | -196.00% | 0.32x | 0.00x | €-11.58 Million |
| 2021 | 0.00% | -174.61% | 0.31x | 0.00x | €-12.41 Million |
| 2022 | 0.00% | -149.49% | 0.38x | 0.00x | €-9.19 Million |
| 2023 | 0.00% | -33.80% | 0.48x | 0.00x | €-2.00 Million |
| 2024 | 0.00% | -135.91% | 0.47x | 0.00x | €-7.97 Million |
Industry Comparison
This section compares Mauna Kea Technologies SAS's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $35,306,105
- Average return on equity (ROE) among peers: -14.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mauna Kea Technologies SAS (ALMKT) | €-29.42 Million | -56.73% | N/A | $28.43 Million |
| Affluent Medical SAS (AFME) | $43.53 Million | -34.04% | 0.61x | $110.43 Million |
| Biosynex (ALBIO) | $66.29 Million | 47.32% | 0.90x | $15.74 Million |
| Bluelinea SA (ALBLU) | $1.41 Million | -89.92% | 5.64x | $9.16 Million |
| Carmat (ALCAR) | $-43.76 Million | 0.00% | 0.00x | $6.37 Million |
| Diagnostic Medical Systems SA (ALDMS) | $23.35 Million | -3.64% | 0.72x | $34.50 Million |
| Eurobio Scientific SA (ALERS) | $175.17 Million | 2.76% | 0.81x | $236.10 Million |
| Ikonisys SA (ALIKO) | $6.09 Million | -30.86% | 0.34x | $21.30 Million |
| Implanet SA (ALIMP) | $6.93 Million | 0.00% | 0.70x | $32.93 Million |
| Mediantechn (ALMDT) | $38.74 Million | -23.52% | 0.20x | $200.33 Million |
About Mauna Kea Technologies SAS
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more